BioMedWire: Chronic conditions and rare diseases in the aging population present an urgent and expanding challenge within the U.S. healthcare system, especially as more than 30 million Americans are ...

Opdivo (nivolumab), in combination with Yervoy (ipilimumab), is indicated for the treatment of adult and paediatric patients 12 years and older with unresectable or metastatic microsatellite ...

Sam Farley breaks down his best early Colts vs. Jaguars predictions ahead of Sunday's massive AFC South showdown.

We scoured the internet to find the best Mexican restaurant in every single U.S. state, from Alaska to Virginia to Florida ...

Bristol Myers Squibb BMY obtained the European Commission’s (“EC”) approval for a label expansion of Breyanzi (lisocabtagene ...

More lawmakers are showing themselves out of Congress instead of running for reelection amid complaints about the legislative ...

Drug maker Bristol Myers Squibb Co. (BMY) announced Monday positive and promising data from the trials in Hematology pipeline, comprising Iberdomide, Golcadomide, BCL6 ...

Hoth Therapeutics, Inc. , a patient focused biopharmaceutical company, today announced that Robb Knie, Chief Executive Officer, is scheduled to present at the Noble Capital Markets 21st Annual ...

Bristol Myers Squibb Data at ASH 2025 Showcases Potential of Hematology Pipeline and Builds Momentum for Next Generation Portfolio ...

UPS MD11 at Louisville on Nov 4th 2025, burst into flames on takeoff A UPS United Parcel Service McDonnell Douglas MD-11, ...

The FDA’s docket in December includes decisions for two big biologic franchises: BMS’s Breyanzi and Amgen’s Uplizna.

A public viewing for Indian River County sheriff's Sgt. Terri Sweeting-Mashkow is today. The viewing from 2-6 p.m. Dec. 1 at ...